&Partners’s Eastman Chemical EMN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.2M Buy
17,847
+1,275
+8% +$93.2K ﹤0.01% 1298
2026
Q1
$1.26M Buy
16,572
+7,330
+79% +$528K 0.01% 1165
2025
Q4
$589K Buy
9,242
+2,074
+29% +$128K ﹤0.01% 1522
2025
Q3
$448K Sell
7,168
-287
-4% -$20K ﹤0.01% 1524
2025
Q2
$517K Sell
7,455
-699
-9% -$54.9K ﹤0.01% 1341
2025
Q1
$709K Buy
8,154
+645
+9% +$60.9K 0.01% 974
2024
Q4
$698K Buy
7,509
+2,079
+38% +$213K 0.01% 916
2024
Q3
$608K Buy
+5,430
New +$543K 0.01% 773

Other funds holding EMN

&Partners's EMN Position: Q2 2026 in Review

&Partners increased its Eastman Chemical (EMN) stake by 7.7% in Q2 2026, buying an estimated $93.2K and bringing the position to 17,847 shares worth $1.2M. The position accounts for ﹤0.01% of the portfolio, ranked #1298.

&Partners first reported a position in EMN in Q3 2024 and has held it in 8 quarters since. The position peaked at $1.26M in Q1 2026. 642 funds tracked by Wall St. Rank hold EMN as of Q2 2026.

  • &Partners held 17,847 shares of Eastman Chemical worth $1.2M as of Q2 2026.
  • &Partners bought 1,275 Eastman Chemical shares in Q2 2026, an estimated $93.2K.
  • Eastman Chemical made up ﹤0.01% of &Partners's portfolio in Q2 2026, its #1298 holding.
  • &Partners first reported a position in Eastman Chemical in Q3 2024 and has held it in 8 quarters since.
  • &Partners's Eastman Chemical position peaked at $1.26M in Q1 2026.
  • 642 funds tracked by Wall St. Rank held Eastman Chemical as of Q2 2026.

Based on &Partners's 13F filing for Q2 2026, filed 14 Aug 2026.